We recognize July as Minority Mental Health Month and use it as an opportunity to educate and bring awareness. Historically marginalized communities across America face unique mental health challenges, and we’re working to provide valuable resources to help. Barriers to…
UnitedHealthcare Community Plan of Arizona has been awarded the industry-recognized Health Plan Accreditation and Long-Term Services and Supports (LTSS) Distinction by the National Committee for Quality Assurance (NCQA). NCQA accredits and certifies a wide range of health care organizations and…
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, will support the Special Olympics Healthy Athletes® screenings at the Special Olympics World Games, that take place from 17 to 25 June 2023 in Berlin,…
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), Defibtech, and the Professional Football Athletic Trainers Society Foundation Inc. (PFATS Foundation), are coming together to donate and distribute automated external defibrillators (AEDs). Recognizing the importance of having AEDs readily available for student athletes,…
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2023 State of Telemedicine Report, revealing that nearly 88% of U.S. physicians surveyed believe telemedicine has increased patient access to health care, particularly among populations that…
More than 2,800 attendees including pharmacists, independent pharmacy owners, technicians, exhibitors and McKesson experts came together last week at the 2023 McKesson ideaShare conference in Las Vegas. The annual event, which is hosted by McKesson Corporation, Health Mart, and Health Mart Atlas, is the leading…
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and…
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for fidanacogene elaparvovec for the treatment of adults with hemophilia B. In parallel, the European marketing authorization application (MAA)…
The company will showcase its latest innovative solutions to enable rapid diagnosis, Theranostics, and precision care at #SNMMI23 CHICAGO — At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting, GE HealthCare (Nasdaq: GEHC) is proud to…
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2023 State of Telemedicine Report, revealing that nearly 88% of U.S. physicians surveyed believe telemedicine has increased patient access to health care, particularly among populations that…
The At-Home in vitro diagnostic (IVD) testing market is comprised of IVD tests that can be purchased at the local store or on the Internet where the patient gathers the specimen and results are displayed usually within minutes. Generally, these…
Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with platinum-based chemotherapy for the neoadjuvant treatment of resectable non-small cell lung cancer (NSCLC) at high risk of recurrence in adult patients with tumor cell…